Full-Time

Sub Investigator

Care Access

Care Access

501-1,000 employees

Global health education, access, and research

Compensation Overview

$120k - $150k/yr

No H1B Sponsorship

Fayetteville, NC, USA

In Person

Regular regional travel is required, including travel with 24–36-hour notice.

Master's

Category
Biology & Biotech (1)
Required Skills
Phlebotomy
Medical Terminology
Word/Pages/Docs
Quality Assurance (QA)
Vital Signs
Excel/Numbers/Sheets

Get referred to Care Access

See people who can refer or advise you

Requirements
  • A Master's-level science degree is required.
  • A Nurse Practitioner or Physician Assistant credential with at least 5 years of clinical experience is required.
  • Current licensure in good standing in one or more states is required.
  • Clinical practice experience with an infusion skillset is desired.
  • At least 1 year of relevant Sub-Investigator experience in a clinical research setting is preferred.
  • At least 1 year of Clinical Research Coordinator experience is preferred, or willingness to learn.
  • Ability to perform and document vital signs and electrocardiograms is required.
  • Phlebotomy and expert intravenous skills are required.
  • Working knowledge of medical and research terminology, federal regulations, and Good Clinical Practice is required.
  • Strong verbal and written communication skills are required.
  • Strong organizational skills and the ability to prioritize and follow through on assignments are required.
  • Strong computer skills with clinical trials databases, intravenous response systems, electronic data capture, Microsoft Word, and Microsoft Excel are required.
  • Ability to work independently, balance competing priorities, and apply critical thinking and problem-solving is required.
  • Ability to lift a minimum of 50 pounds is required.
  • Professional and business English proficiency, written and spoken, is required.
  • Authorization to work in the United States for any employer is required, without current or future visa sponsorship.
  • Living in the United States and willingness and ability to travel with 24–36-hour notice are required.
Responsibilities
  • Work closely with the Principal Investigator to oversee execution of study protocols, delegate study-related duties to site staff as appropriate, and ensure compliance with protocols, laboratory procedures, Good Clinical Practice, Standard Operating Procedures, quality procedures, Occupational Safety and Health Administration guidelines, and applicable regulations.
  • Attend and participate in meetings with the director, managers, and staff as necessary.
  • Read and understand informed consent forms, protocols, and investigator brochures.
  • See study subjects virtually or in person as dictated by project design, answer questions, and resolve medical issues during study visits.
  • Sign and ensure completion of study documentation for each study visit.
  • Perform study responsibilities in compliance with the Institutional Review Board-approved protocol.
  • Administer investigational products through subcutaneous, transdermal, intramuscular, intravenous, and oral routes.
  • Start, monitor, and maintain intravenous lines.
  • Perform phlebotomy, blood collection, and laboratory processing practices.
  • Participate in management of infusion and other investigational-product-related reactions.
  • Maintain a clean and efficient clinical area and follow safety, personal protective equipment, and infusion-documentation procedures.
  • Communicate promptly with internal teams, investigators, review boards, and study subjects.
  • Prescreen study candidates by telephone and review exclusionary conditions or medications before scheduling screening appointments.
  • Obtain informed consent according to Standard Operating Procedures.
  • Administer delegated study questionnaires as appropriate.
  • Collect and evaluate medical records.
  • Complete visit procedures and ensure specimen collection, processing, and shipment according to protocol.
  • Train others and complete basic clinical procedures, including blood draws, vital signs, and electrocardiograms.
  • Review screening documentation and approve subjects for study admission.
  • Review admission documentation and approve subjects for randomization.
  • Assess study subjects to identify adverse events.
  • Ensure serious and unexpected adverse events are promptly reported to the Principal Investigator.
  • Review and evaluate study data and assess the clinical significance of out-of-range results.
  • Perform physical examinations during screening and active study conduct.
  • Provide medical management of adverse events as appropriate.
  • Dispense study medication according to protocol or intravenous response systems, educate patients on proper administration, and reinforce compliance.
  • Monitor patient progress while receiving study medication.
Desired Qualifications
  • Clinical practice experience with an infusion skillset.
  • At least 1 year of relevant work experience as a Sub-Investigator in a clinical research setting.
  • At least 1 year of experience as a Clinical Research Coordinator, or willingness to learn.

Care Access coordinates global efforts to improve health by educating people about health, helping them access needed resources, and enabling participation in medical research to develop new medicines and cures. Its approach involves a global network and services that educate individuals, connect them with health resources, and recruit participants for clinical studies, thereby supporting the development of new treatments. Unlike companies that focus on a single market or product, Care Access operates worldwide and focuses on easing access to information, services, and research opportunities for diverse populations. The goal is to make health information and access more available and participation in health studies easier, with the aim of making the future of health better for everyone.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Boston, Massachusetts

Founded

2016

Get referred to Care Access

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Walmart opened first Texas and Georgia sites on April 29, 2026.
  • Association of Black Cardiologists partnership expands heart-health screenings and trial recruitment.
  • Brazil acquisition and Warsaw opening extend Care Access's footprint into two new geographies.

What critics are saying

  • Walmart becomes a single-channel dependency if store rollout stalls after April 2026.
  • Poland, Brazil, and Texas expansions raise compliance complexity and operational failure risk.
  • Pharma sponsor pullbacks kill utilization; empty sites erase Care Access's decentralized advantage.

What makes Care Access unique

  • Care Access runs trials inside Walmart stores, closer to patients than traditional sites.
  • Its community screening model turns everyday health events into recruitment funnels for studies.
  • Global decentralization spans Brazil, Poland, and mobile infrastructure, not just U.S. clinics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-4%

2 year growth

-4%
8th & Walton
Apr 29th, 2026
Walmart brings clinical trials into the community - walmart.com.

Walmart brings clinical trials into the community - walmart.com. Walmart is bringing clinical research into everyday community spaces through the Walmart Healthcare Research Institute and a new Clinical Trial Center collaboration with Care Access. Key takeaways. * Research closer to home: The Clinical Trial Center by Walmart and Care Access is opening initial sites in Houston and Tyler, Texas, and Dalton, Georgia, placing trial locations inside familiar store environments. * Focus on underserved communities: Walmart Healthcare Research Institute was created to expand access to clinical trials and improve care for communities historically underrepresented in research. * New model for medical innovation: Care Access will run screenings and trials, while Walmart supports outreach, with leaders describing the effort as a new way to deliver clinical research.

SmartBrief
Jan 22nd, 2026
Walmart, Care Access to partner on clinical research

Walmart, Care Access to partner on clinical research. Walmart will partner with Care Access to launch a clinical research initiative this spring that will bring clinical trial opportunities to markets, including rural areas that often lack access to cutting-edge medical research. The retailer will open research sites at select stores and former Walmart Health clinic locations. By using familiar community spaces, Walmart hopes to make participation in clinical research more accessible and convenient for local residents. Designed specifically for retail professionals, NRF SmartBrief is a free, daily email newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition.

First Free Church Chicago
Dec 1st, 2024
Care Access Senior Fair | December 6 + 7

On December 6th and 7th Firstfree is partnering with Care Access, an organization with a mission to connect the community with equitable health research.

Business Wire
Mar 18th, 2024
Care Access Opens New Clinical Research Site In Warsaw, Poland

BOSTON--(BUSINESS WIRE)--Care Access, a global clinical research site company helping to accelerate the future of medicine, has opened its newest research site in Warsaw, Poland. The company’s expansion in Poland reinforces its commitment to improving access to clinical research globally through its innovative model of bringing clinical trials wherever they are needed. In recent years, Care Access has been active in clinical research across Europe, and now, by establishing a new facility in Warsaw, Care Access is further expanding its European services aimed to implement its industry-leading research capabilities, such as its Community Screening Program, Sites On Demand, and Mobile Research Site Infrastructure. These capabilities have shown to accelerate research study enrollment by adapting to the unique makeup of each community and providing more convenient ways to participate in clinical trials. “Poland plays an important role in bringing the future of medicine to reality,” said Rupi Bancil, Senior Vice President of Global Study Operations Expansion for Care Access. “The Warsaw site will improve access to advanced health screenings and research opportunities to communities throughout Poland.”

Business Wire
Mar 4th, 2024
New Study Addressing Global Concern For Breast Cancer Treatment Now Available In Clifton, N.J.

BOSTON--(BUSINESS WIRE)--A cancer research study focusing on hormone receptor-positive HER2-negative (HR+/HER2-) metastatic breast cancer (MBC) is now available to patients in the Clifton, N.J., area. The SERENA-6 trial, sponsored by AstraZeneca, is a global study that aims to address a critical issue faced by many patients: their treatments become less effective over time. In advanced breast cancer, patients receive a treatment that combines an estrogen-reducing drug with a drug that slows cancer cell growth. While this combination works well, over time, it may stop working because of mutations in the ESR1 gene. This study will evaluate if an experimental trial drug, combined with a cancer-slowing drug, might work better than conventional estrogen-reducing drugs for patients with ESR1 mutations